Safety
sleepiness, decubitus, somnolence
ADVERSE EVENTS, ADVERSE EVENT, DECUBITUS
During the 36‐month study period, 488 exposure procedures were performed in patients (median, 7.0 per patient [range, 1–42]) and 51 in healthy volunteers (one per volunteer, per protocol). All healthy volunteers tolerated the procedure. Two excluded patients were unable to tolerate decubitus during the pre‐exposure resting period (which was therefore unrelated to EMF exposure). No serious adverse events were reported during procedures. CTCAE grade 1 somnolence was the only adverse event, occurring in 52/66 patients (78.8%) and in 25/51 healthy volunteers (49.0%). This was characterized by mild but more than usual drowsiness or sleepiness, started within minutes of exposure initiation and ended spontaneously upon completion. All participants were able to resume normal activities after discharge.